Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
GLPG | Amsterdam | EUR | Real-time | |
GLPGa | BATS Europe | EUR | Delayed | |
GLPG | NASDAQ | USD | Real-time | |
GLPGF | OTC Markets | USD | Delayed | |
GLPG | Vienna | EUR | Real-time |
Index | Last | High | Low | Chg. | Chg. % | Time | ||
---|---|---|---|---|---|---|---|---|
BEL 20 | 3,874.00 | 3,890.10 | 3,867.80 | -9.26 | -0.24% | 07:04:15 | ||
Health Care NR | 4,090.72 | 4,090.72 | 4,090.72 | +26.49 | +0.65% | 30/04 | ||
AEX All Share | 1,187.21 | 1,197.15 | 1,186.43 | -6.92 | -0.58% | 30/04 | ||
AMX | 915.44 | 927.85 | 915.44 | -10.56 | -1.14% | 30/04 | ||
Next 150 | 3,367.22 | 3,392.89 | 3,366.94 | -16.61 | -0.49% | 30/04 | ||
Next Biotech | 2,087.71 | 2,087.71 | 2,087.71 | +9.06 | +0.44% | 30/04 | ||
AEX Health Care | 1,445.93 | 1,470.00 | 1,432.96 | -15.89 | -1.09% | 30/04 | ||
STOXX 600 | 504.10 | 504.74 | 502.78 | -0.80 | -0.16% | 07:03:30 | ||
BEL 20 GR | 12,289.96 | 12,289.96 | 12,289.96 | -11.06 | -0.09% | 30/04 | ||
BEL 20 Net Return | 9,094.96 | 9,094.96 | 9,094.96 | -8.18 | -0.09% | 30/04 | ||
BEL Continuous Stocks Net Return | 53,424.22 | 53,855.36 | 53,401.45 | -140.06 | -0.26% | 30/04 | ||
BEL All Share Net Return | 57,554.09 | 57,554.09 | 57,554.09 | -150.04 | -0.26% | 30/04 | ||
BEL All Share | 13,927.89 | 14,039.46 | 13,922.09 | -37.09 | -0.27% | 30/04 | ||
STXE Health Care PR | 1,145.20 | 1,145.83 | 1,137.70 | -0.84 | -0.07% | 01/05 | ||
AMX Gross | 3,179.20 | 3,222.29 | 3,179.20 | -36.67 | -1.14% | 30/04 | ||
EN BENE 40 EW | 2,806.92 | 2,824.57 | 2,803.91 | -11.04 | -0.39% | 30/04 | ||
BEL 20 X5 Leverage NR | 335.79 | 344.60 | 334.47 | -1.67 | -0.49% | 30/04 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review